APERITIF tested low-dose rivaroxaban+ DAPT vs DAPT alone to prevent LV thrombus after anterior STEMI. Primary endpoint: LVT on contrast-enhanced CMR at 1 month. Result: no significant difference (13.7% vs 16.6%, p=.34).But there's a screening problem worth discussing. jamanetwork.com/journals/jam...

academic.oup.com/eurheartj/ad... @escardio.bsky.social #Cardiosky #WhyCMR #Epeeps #Medsky Please DM me if you would like a full-text PDF of the paper!

Thank you, @toddneale.bsky.social, for your excellent reporting on our EHJ paper! @tctmd.bsky.social @escardio.bsky.social @paragbawaskar.bsky.social

Query sarcoid, normal #WhyCMR, so then should we do FDG-PET? Not much benefit.

Read our accompanying editorial for our thoughts on the important paper – academic.oup.com/ehjcimaging/... @paragbawaskar.bsky.social #CardioSky #MedSky #Sarcoidosis

In patients with suspected cardiac sarcoidosis, cardiac FDG-PET is recommended after a normal CMR if there is a high clinical suspicion. What are the data supporting this recommendation? #CardioSky #MedSky #Sarcoidosis

This paper reports the coexistence of cardiac sarcoidosis and arrhythmogenic cardiomyopathy in 5 patients. heart.bmj.com/content/earl... #CardioSky #MedSky

In honor of Dr. Braunwald’s 95th birthday. The number of areas he has touched in cardiology is staggering, and number of cardiovascular professionals is unquantifiable. @harvardmed.bsky.social

Amazing achievement by rising star and post-doc in my lab @paragbawaskar.bsky.social, winner of the prestigious 2024 Melvin Judkins Early Career Investigator Award at #AHA24!! Congratulations!!! @ahascience.bsky.social

It’s great that journals are coming over here, but what I have really missed after my departure from Twitter 2 years ago is this, the authors themselves presenting their works and discussing it with peers. #cardiosky #medsky #emimcc

In 2019, we wrote a paper showing that patients with left ventricular thrombus have a long-term risk of embolism, extending to at least 8 years. We were puzzled by the finding… #CardioSky www.ahajournals.org/doi/10.1161/...

Have you ever wondered whether your patient with CAD and cardiomyopathy truly has ischemic cardiomyopathy, or whether the CAD is a “bystander”? You might be interested in our paper now out in Circulation #simultaneouspublication #AHA23 #cardiosky #Medsky #WhyCMR